News Quantified

TSVT – 2seventy bio, inc. (US:NASDAQ)

2seventy bio, Inc. (NASDAQ: TSVT) was upgraded by analysts at Canaccord Genuity Group Inc. to a "strong-buy" rating.

2seventy bio, Inc. (NASDAQ: TSVT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.

2seventy bio Reports First Quarter Financial Results and Recent Operational Progress [Yahoo! Finance]

2seventy bio Reports First Quarter Financial Results and Recent Operational Progress

2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}